ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL

Objective: to investigate the impact of treatment with subcutaneous methotrexate (MTX) and combined therapy with MTX and biological agents (BA) on the serum level of matrix metalloproteinase 3 (MMP3); to estimate the informative value of determination of MMP3 levels for predicting the clinical effic...

ver descrição completa

Detalhes bibliográficos

Principais autores:	A. S. Avdeeva, E. N. Aleksandrova, D. E. Karateev, E. L. Luchikhina, M. V. Cherkasova, E. L. Nasonov
Formato:	Artigo
Idioma:	Russo
Publicado em:	IMA PRESS LLC 2016-03-01
Colecção:	Научно-практическая ревматология
Assuntos:	rheumatoid arthritis matrix metalloproteinase 3 methotrexate biological agents
Acesso em linha:	https://rsp.mediar-press.net/rsp/article/view/2167
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!